Mellema, J. J., Stockem, C., Herberts, C., Cheung, S. K., Vis, D. J., Rhijn, B. W. V., Mertens, L., Boellaard, T. N., Montfoort, M. L. V., Balduzzi, S., Feijter, J. D., Mijn, J. C. V. D., Boormans, J. L., Franckena, M., Meijer, R., Noteboom, J. L., Schaake, E. E., Robbrecht, D. G., Suelmann, B. B., Heijden, M. S. V. D. (2026). Induction ipilimumab plus nivolumab followed by consolidating chemoradiotherapy as bladder-sparing treatment in stage II/III urothelial carcinoma of the bladder: The phase 2 Indi-Blade trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.lba637